Zacks' 7 Best Stocks for June, 2013
FREE Report for Zacks.com
Visitors Only

They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.

Today, you can see them free.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/21/2013

Company Name Symbol %Change
SCIENTIFIC L SCIL
8.00%
NATUS MEDICA BABY
6.11%
SUMMER INFAN SUMR
6.02%
RADIANT LOGI RLGT
5.32%
NEW ORIENTAL EDU
4.51%

Regions Closes Morgan Keegan Sale

by Zacks Equity Research

April 03, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

On Monday, Regions Financial Corp. ( RF - Analyst Report ) finally completed the sale of its securities brokerage arm, Morgan Keegan & Company, Inc. to Raymond James Financial Inc. ( RJF - Analyst Report ) . The purchase price amounted to about $1.2 billion.

Previously, as per the terms of the deal, with the purchase price of $930 million, Regions was supposed to receive a dividend of $250 million from Morgan Keegan. Instead, Raymond James increased the purchase price by approximately the same amount of dividend and closed the deal for higher than the agreed amount.

However, Morgan Asset Management and Regions Morgan Keegan Trust are retained as part of Regions’ Wealth Management organization.

It is expected that Regions will use the proceeds of the deal along with $900 million generated from common stock offering in March in repaying its $3.5 billion dues related to the Troubled Asset Relief Program (TARP). The repayment of TARP dues awaits approval of the Federal Reserve and Treasury Department.

Following the divestiture, Regions aims to concentrate on its core banking business while providing products and services to its clients in a better way. Moreover, the company will have strong revenue opportunities through the business relationship with Raymond James. The two firms are anticipated to start several mutually beneficial business relationships, including deposits, loan referrals and processing, which would benefit the shareholders in the long run.

John Carson, CEO of Morgan Keegan, aims to continually offer its exceptional services to individual and institutional clients after becoming a part of Raymond James. Additionally, Regions and Raymond James ensure providing same level of service to Morgan Keegan’s customers with Regions’ banking relationships.

After the completion of the deal, Raymond James laid off 218 positions, representing less than 2% of about 13,000 workers of the combined firms. Out of the total jobs cut, 143 were at Morgan Keegan and 75 were removed from Raymond James. The equity capital markets and fixed-income groups specially witnessed a reduction in number of staff.

The agreement depicts Florida-based Raymond James’ expansion strategies to move ahead with smaller acquisitions. Though the firm emphasizes on organic growth, great opportunity at right time along with correct price are subjects to be addressed. For Raymond James, it is the most important agreement it has ever entered into, which in turn would expand its brokerage and capital markets business.

Regions currently retain a Zacks #2 Rank, which translates into a short-term Buy rating. However, considering the fundamentals, we maintain a long term Neutral rating on the stock.

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.